פלולן אפופרוסטנול 500 מקג לעירוי 以色列 - 希伯来文 - Ministry of Health

פלולן אפופרוסטנול 500 מקג לעירוי

glaxo smith kline (israel) ltd - epoprostenol as sodium - אבקה להכנת תמיסה לאינפוזיה - epoprostenol as sodium 0.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the long-term intravenous treatment of primary pulmonary hypertension and pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

רייאטאז 200 מג 以色列 - 希伯来文 - Ministry of Health

רייאטאז 200 מג

bristol - myers squibb, israel - atazanavir as sulfate - קפסולות - atazanavir as sulfate 200 mg - atazanavir - atazanavir - reyataz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

בימקטין פסטה לסוסים וטרינרי 以色列 - 希伯来文 - Ministry of Health

בימקטין פסטה לסוסים וטרינרי

eliezer linevitz ltd. - ivermectin - פסטה - ivermectin 18.7 mg/g

רייאטאז 300 מג 以色列 - 希伯来文 - Ministry of Health

רייאטאז 300 מג

bristol - myers squibb, israel - atazanavir as sulfate - קפסולות - atazanavir as sulfate 300 mg - atazanavir

אפופרוסטנול טבע ® 1.5 מ"ג 以色列 - 希伯来文 - Ministry of Health

אפופרוסטנול טבע ® 1.5 מ"ג

salomon,levin & elstein ltd - epoprostenol as sodium 1.5 mg - powder and solvent for solution for infusion - epoprostenol - epoprostenol teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

אפופרוסטנול טבע ® 0.5 מ"ג 以色列 - 希伯来文 - Ministry of Health

אפופרוסטנול טבע ® 0.5 מ"ג

salomon,levin & elstein ltd - epoprostenol as sodium 0.5 mg - powder and solvent for solution for infusion - epoprostenol - epoprostenol teva is indicated for the long-term intravenous treatment of primary arterial pulmonary hypertension and arterial pulmonary hypertension associated with the scleroderma spectrum of disease in nyha class iii and class iv patients who do not respond to conventional therapy.

רימודולין 5 מגמל 以色列 - 希伯来文 - Ministry of Health

רימודולין 5 מגמל

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

רימודולין 2.5 מגמל 以色列 - 希伯来文 - Ministry of Health

רימודולין 2.5 מגמל

rafa laboratories ltd - treprostinil as sodium - תמיסה להזרקה - treprostinil as sodium 2.5 mg/ml - treprostinil - treprostinil - remodulin is indicated as a continuous subcutaneous infusion or intravenous infusion for the treatment of primary pulmonary arterial hypertension and pulmonary arterial hypertension associated with connective tissue disorders. pulmonary hypertension associated with congenital systemic to pulmonary shunts.

אביטרקסט תמיסה 1 גרם/10 מ"ל 以色列 - 希伯来文 - Ministry of Health

אביטרקסט תמיסה 1 גרם/10 מ"ל

salomon,levin & elstein ltd - methotrexate 1000 mg / 10 ml - solution for injection - methotrexate - antineoplastic chemotherapy.psoriasis. rheumatoid arthritis.

מתוטרקסאט "אבווה" 10 מ"ג/מ"ל 以色列 - 希伯来文 - Ministry of Health

מתוטרקסאט "אבווה" 10 מ"ג/מ"ל

pharmalogic ltd - methotrexate 10 mg/ml - solution for injection - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. palliation of acute lymphocytic leukemia. in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, methotrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. methotrexate is effective in the treatment of the advanced stages (iii and iv peter's staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. psoriasis: because of the high risk attending its use, methotrexate is indicated only in the